Related Experiment Video
Updated: May 17, 2026
10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Meningococcal disease: changes in epidemiology and prevention.
Qiuzhi Chang1, Yih-Ling Tzeng, David S Stephens
1Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
Clinical Epidemiology
|October 17, 2012
Summary
New vaccines are controlling Neisseria meningitidis infections, a major global health threat. Continued surveillance is vital for understanding disease patterns and guiding future prevention strategies against meningococcal disease.
Area of Science:
- Microbiology
- Epidemiology
- Vaccinology
Background:
- Neisseria meningitidis is a significant global pathogen causing serious health threats.
- Meningococcal disease epidemiology varies geographically and temporally, influenced by serogroups and genotypes.
- Serogroups A, B, C, Y, W-135, and X are responsible for most invasive meningococcal disease globally.
Purpose of the Study:
- To review current knowledge on the global epidemiology and pathophysiology of meningococcal disease.
- To summarize recent advances in the prevention of meningococcal infections through new vaccines.
- To highlight the importance of ongoing surveillance for understanding and predicting disease dynamics.
Main Methods:
- Literature review of global epidemiology of Neisseria meningitidis.
- Analysis of pathophysiology of meningococcal disease.
- Evaluation of recent advances in meningococcal vaccine development and implementation.
Main Results:
- Significant declines in meningococcal disease observed in developed countries, partly due to new vaccines.
- Introduction of serogroup C conjugate vaccines and multivalent A, C, W-135, Y conjugate vaccines has expanded use.
- New serogroup A conjugate vaccines introduced in sub-Saharan Africa; progress in serogroup B vaccines ongoing.
- Conjugate vaccines demonstrate effectiveness through prevention of transmission and herd immunity.
Conclusions:
- New meningococcal vaccines have significantly contributed to disease control.
- Continued global surveillance is essential for adapting prevention strategies.
- Understanding epidemiological and biological shifts is crucial for future vaccine development and public health interventions.
Related Concept Videos
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...